General MedicationsORALGeneric

TAVIST-1

CLEMASTINE FUMARATE

Standard Dose

1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview TAVIST-1 is listed in Drugs@FDA under application 020925 (NDA).

Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength TABLET;ORAL - 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HALEON US HOLDINGS Submission history Latest submission status date: 2002-06-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAVIST-1 is listed in Drugs@FDA under application 020925 (NDA). Marketing status: Discontinued Active ingredient CLEMASTINE FUMARATE Form and strength TABLET;ORAL - 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HALEON US HOLDINGS Submission history Latest submission status date: 2002-06-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.